RB1 and neoplasm: We used wild-type (wt) RB1 mutation status as a surrogate, albeit imperfect marker of YAP1 expression (see cell line data in Figure 5A) and examined its association with survival in a third cohort of SCLC patients with tumor exon-sequencing data (Supplementary Table S4) [18].